Reuters - TORONTO, Jan 22 (Reuters) - Ambrilia Biopharma Inc (AMB.TO: Quote , Profile , Research ) said on Tuesday preliminary Phase III results of show its Octreotide induced a "highly statistically significant decrease" of Growth Factor and Growth Hormone ...
- Recent posts
- Ambrilia says Octreotide drug effective in test
- Andy Pettitte and HGH, the Humanizing Hormone
- Knoblauch Is Subpoenaed By Congressional Committee
- Knoblauch, former Clemens teammate, receives subpoena from Congress
- The Power Of HGH
- Knoblauch, former Clemens teammate, receives subpoena from Congress
- House committee issues subpoena to former Yankee Chuck Knoblauch
- Tercica Starts Phase II Clinical Trial With Next-Generation Growth ...
- Tercica Initiates Phase II Clinical Trial with Next-Generation Growth ...
- Why We Love Justice (and Shouldn't)
- House committee issues subpoena to former Yankee Chuck Knoblauch
- Metabolic Control and Growth during Exclusive Growth Hormone...
- Cyclists in Amgen Tour of California will face stringent anti-doping ...
- Even Celebrities Aren't Safe From The Human Growth Hormone Hunt
- Human Growth Hormone, buy Human Growth Hormone, cheap hgh
- Lowell: Baseball held to higher standard
- ROGER'S PREEMPTIVE STRIKE
- Clemens, Pettitte asked to testify before Congress
- Sports at 2:15 p.m.
- Roger Clemens throws a slider: admits to injections